BARD1 and cancer: Down-regulation of FL BARD1 can have oncogenic effects [5,11,20,21] whereas BARD1 isoforms that lack RING or/and ANK domains are often up-regulated and associated with negative prognosis in breast [15], ovarian [15] endometrial [77] and lung [78] cancers.